JP2007501809A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501809A5
JP2007501809A5 JP2006522859A JP2006522859A JP2007501809A5 JP 2007501809 A5 JP2007501809 A5 JP 2007501809A5 JP 2006522859 A JP2006522859 A JP 2006522859A JP 2006522859 A JP2006522859 A JP 2006522859A JP 2007501809 A5 JP2007501809 A5 JP 2007501809A5
Authority
JP
Japan
Prior art keywords
compound
formula
reacting
substituted
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006522859A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007501809A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2004/001466 external-priority patent/WO2005014585A1/en
Publication of JP2007501809A publication Critical patent/JP2007501809A/ja
Publication of JP2007501809A5 publication Critical patent/JP2007501809A5/ja
Withdrawn legal-status Critical Current

Links

JP2006522859A 2003-08-08 2004-08-06 抗菌剤としてのハロゲン化キナゾリニルニトロフラン Withdrawn JP2007501809A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49333603P 2003-08-08 2003-08-08
PCT/CA2004/001466 WO2005014585A1 (en) 2003-08-08 2004-08-06 Halogenated quinazolinyl nitrofurans as antibacterial agents

Publications (2)

Publication Number Publication Date
JP2007501809A JP2007501809A (ja) 2007-02-01
JP2007501809A5 true JP2007501809A5 (enExample) 2007-09-20

Family

ID=34135234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006522859A Withdrawn JP2007501809A (ja) 2003-08-08 2004-08-06 抗菌剤としてのハロゲン化キナゾリニルニトロフラン

Country Status (9)

Country Link
US (1) US7410974B2 (enExample)
EP (1) EP1660486A4 (enExample)
JP (1) JP2007501809A (enExample)
CN (1) CN1832941A (enExample)
AU (1) AU2004262533A1 (enExample)
BR (1) BRPI0413372A (enExample)
CA (1) CA2534405A1 (enExample)
MX (1) MXPA06001552A (enExample)
WO (1) WO2005014585A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010016646A1 (en) * 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
JP2007501809A (ja) 2003-08-08 2007-02-01 ユリシーズ・ファーマシューティカル・プロダクツ・インコーポレイテッド 抗菌剤としてのハロゲン化キナゾリニルニトロフラン
US20080146562A1 (en) * 2003-08-08 2008-06-19 Ulysses Pharmaceutical Products Inc., Halogenated quinazolinyl nitrofurans as antibacterial agents
WO2006032138A1 (en) * 2004-09-23 2006-03-30 Ulysses Pharmaceutical Products Inc. Carbo- and hetero-cyclic antibiotics and use thereof
WO2007101274A2 (en) * 2006-03-02 2007-09-07 The Uab Research Foundation Mycobacterial disease detection, treatment, and drug discovery
US20110053964A1 (en) * 2006-08-22 2011-03-03 Roger Tung 4-aminoquinazoline derivatives and methods of use thereof
EP2054063A4 (en) * 2006-08-22 2010-10-27 Concert Pharmaceuticals Inc 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE
WO2008113161A1 (en) * 2007-03-19 2008-09-25 Ulysses Pharmaceutical Products Inc. Phosphate prodrugs of quinazolinyl nitrofurans, methods of obtaining, and use of same
WO2011121345A1 (en) 2010-03-30 2011-10-06 Helperby Therapeutics Limited Novel combination and use
ES2826884T3 (es) 2010-08-05 2021-05-19 Helperby Therapeutics Ltd Combinación de un compuesto de pirroloquinolina y un agente antimicrobiano betalactámico, mupirocina o clorhexidina
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
GB201305277D0 (en) 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201307989D0 (en) 2013-05-02 2013-06-12 Helperby Therapeutics Ltd Novel combinations and use
GB201401617D0 (en) 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use
JP6629327B2 (ja) 2014-12-18 2020-01-15 ヘルパービー セラピューティクス リミテッドHelperby Therapeutics Limited 微生物感染の予防または治療で使用される組み合わせ
HK1250679A1 (zh) 2015-04-11 2019-01-11 Helperby Therapeutics Limited 口腔用组合物
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
CN105796564B (zh) * 2016-04-12 2017-07-11 青岛市市立医院 一种防治牙体牙髓感染的药物组合物
GB201610869D0 (en) 2016-06-22 2016-08-03 Helperby Therapeutics Ltd Combination
GB201612093D0 (en) 2016-07-12 2016-08-24 Helperby Therapeutics Ltd Combination
GB201616014D0 (en) 2016-09-20 2016-11-02 Helperby Therapeutics Ltd Combination
GB201616909D0 (en) 2016-10-05 2016-11-16 Helperby Therapeutics Ltd Combination
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
GB201709193D0 (en) 2017-06-09 2017-07-26 Helperby Therapeutics Ltd Combination
CN107021960B (zh) * 2017-06-10 2018-07-31 上海普康药业有限公司 一种治疗恶性肿瘤的药物
CN108690012A (zh) * 2017-06-10 2018-10-23 曹艳 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法
GB201807046D0 (en) 2018-04-30 2018-06-13 Helperby Therapeutics Ltd Combination
GB201913068D0 (en) 2019-09-10 2019-10-23 Helperby Therapeutics Ltd Combination
GB201914847D0 (en) 2019-10-14 2019-11-27 Helperby Therapeutics Ltd Combination
GB202213753D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial combinations
GB202213750D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial
GB202314387D0 (en) 2023-09-20 2023-11-01 Helperby Therapeutics Ltd Antimicrobial combinations

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3324122A (en) 1964-12-14 1967-06-06 Norwich Pharma Co Series of 4-substituted-2-(5-nitro-2-furyl) quinazolines
US3542784A (en) * 1968-04-05 1970-11-24 Norwich Pharma Co 4-(hydroxyanilino)-2-(5-nitro-2-furyl)quinazolines
DE2140280A1 (de) 1970-08-12 1972-02-17 Chemische Fabrik von Heyden GmbH, 8000 München 4 Amino 2 eckige Klammer auf 2 (5 Nitro 2 furyl)vinyl eckige Klammer zu chinazolinderivate, Herstellungsver fahren dafür und Arzneimittel daraus
US3974277A (en) * 1974-09-06 1976-08-10 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines as growth promotants and feed efficiency enhancing agents
US3970648A (en) * 1974-09-06 1976-07-20 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines
US3973021A (en) * 1974-09-06 1976-08-03 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(phydroxyanilino)quinazoline as a bactericide
JP2657760B2 (ja) 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
US6148377A (en) * 1996-11-22 2000-11-14 Mangosoft Corporation Shared memory computer networks
WO1998034115A1 (en) 1997-02-04 1998-08-06 Trega Biosciences, Inc. 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries
US5925527A (en) 1997-02-04 1999-07-20 Trega Biosciences, Inc. Tricyclic Tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries
CN1248248A (zh) 1997-02-28 2000-03-22 辉瑞产品公司 3-芳基-4(3h)-喹唑啉酮化合物的阻转异构体及其作为ampa-受体拮抗剂的应用
NZ336627A (en) 1997-02-28 2000-12-22 Pfizer Prod Inc Atropisomers of 3-heteroaryl-4(3)-quinazolinones for the treatment of neurodegenerative and CNS-trauma related conditions
US6184377B1 (en) 1997-12-15 2001-02-06 Sepracor Inc. Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
US6943159B1 (en) 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
US20020025968A1 (en) 1998-04-15 2002-02-28 Rifat Pamukcu Method for inhibiting neoplastic cells and related conditions by exposure to 4-aminoquinazoline derivatives
US20040131628A1 (en) 2000-03-08 2004-07-08 Bratzler Robert L. Nucleic acids for the treatment of disorders associated with microorganisms
MXPA02010618A (es) 2000-04-25 2004-05-05 Icos Corp Inhibidores de fosfatidilinositol 3-quinasa delta.
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US6479499B1 (en) 2000-06-28 2002-11-12 National Science Council 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
TWI261055B (en) 2001-03-23 2006-09-01 Bayer Corp Rho-Kinase Inhibitors
US7645878B2 (en) 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
WO2003091224A1 (en) 2002-04-26 2003-11-06 Nippon Shinyaku Co., Ltd. Quinazoline derivative and medicine
EP1578362A4 (en) 2002-07-09 2008-11-05 Point Therapeutics Inc COMBINATION THERAPY WITH A BOROPROLINE COMPOUND
JP2007501809A (ja) 2003-08-08 2007-02-01 ユリシーズ・ファーマシューティカル・プロダクツ・インコーポレイテッド 抗菌剤としてのハロゲン化キナゾリニルニトロフラン

Similar Documents

Publication Publication Date Title
JP2007501809A5 (enExample)
JP2004533444A5 (enExample)
JP2020507589A5 (enExample)
JP2002525286A5 (enExample)
JP2002520416A5 (enExample)
JP2005523922A5 (enExample)
JP2008509187A5 (enExample)
JP2006523216A5 (enExample)
JP2006182786A5 (enExample)
JP2004537516A5 (enExample)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2020097577A5 (enExample)
JP2011505356A5 (enExample)
JP2003522198A5 (enExample)
JP2003503449A5 (enExample)
JP2019527724A5 (enExample)
JP2002525323A5 (enExample)
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
JP2020505354A5 (enExample)
JP2007500222A5 (enExample)
RU2005121908A (ru) Производные зн-хиназолин-4-она
JP2004504323A5 (enExample)
JP2004502755A5 (enExample)
JP2010539091A5 (enExample)
JP2006516606A5 (enExample)